nach oben

Reactions Weekly

Erschienen in:

01.12.2018 | Case report

Ipratropium bromide/salmeterol/fluticasone propionate/tiotropium bromide

Halogenoderma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 64-year-old man developed halogenoderma during treatment with tiotropium bromide, salmeterol/fluticasone propionate and ipratropium bromide¹. …

In the main text of the article, it was mentioned that patient took "tiotropium bromide". However, in the discussion section, the author mentioned that the patient took "ipratropium bromide". Conservatively, both drugs were taken as suspects.

Fremlin GA, et al. An unusual case of multiple nodules on the lower legs. Clinical and Experimental Dermatology 43: 959-961, No. 8, Dec 2018. Available from: URL: http://doi.org/10.1111/ced.13664 - United KingdomCrossRefPubMed

Titel: Ipratropium bromide/salmeterol/fluticasone propionate/tiotropium bromide
Halogenoderma: case report
Publikationsdatum: 01.12.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-55085-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Ipratropium bromide/salmeterol/fluticasone propionate/tiotropium bromide

Halogenoderma: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Ibrutinib/rituximab

Prednisolone

Octreotide/pasireotide

Somatrogon

Multiple drugs

Rivaroxaban